GERN · Healthcare · $789M
$1.23-0.81%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“이번 분기 매출은 5,750만 달러로 전 분기보다 11% 늘어, 4,700만 달러에서 4,800만 달러, 5,200만 달러, 5,750만 달러로”
In the company's words · 2026 2분기 earnings call